dc.contributor.author |
Garbe, Claus |
|
dc.date.accessioned |
2021-12-20T09:15:10Z |
|
dc.date.available |
2021-12-20T09:15:10Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1879-0852 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/121871 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejca.2021.01.006 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Neoadjuvant and adjuvant end-points in health technology assessment in oncology |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210512015105_00209 |
|
utue.publikation.seiten |
40-50 |
de_DE |
utue.personen.roh |
Harbeck, Nadia |
|
utue.personen.roh |
Schneeweiss, Andreas |
|
utue.personen.roh |
Thuss-Patience, Peter |
|
utue.personen.roh |
Miller, Kurt |
|
utue.personen.roh |
Garbe, Claus |
|
utue.personen.roh |
Griesinger, Frank |
|
utue.personen.roh |
Eberhardt, Wilfried E. E. |
|
utue.personen.roh |
Klussmann, Jens P. |
|
utue.personen.roh |
Wollenberg, Barbara |
|
utue.personen.roh |
Grimm, Marc-Oliver |
|
utue.personen.roh |
Zander, Thomas |
|
utue.personen.roh |
Lueftner, Diana |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Cancer |
de_DE |
dcterms.isPartOf.ZS-Volume |
147 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |